News

Project providing clean manufacturing space comes to Roanoke

Three Southwest Virginia biomedical companies that need sterile space for manufacturing will be part of a modular cleanroom pilot program.

A $100,000 grant from economic development initiative GO Virginia and $221,500 in non-state money will fund the project, according to a GO Virginia news release. Cancer-fighting businesses Tiny Cargo Co. and Acomhal Research, both in Roanoke, and Blacksburg-based equine therapy specialist Qentoros will use the modular space at Fralin Biomedical Research Institute at VTC, in Roanoke.

Cleanrooms are crucial for making circuit boards, medical equipment, optical products, pharmaceuticals and more in a contamination-free environment with heavily filtered air pumped into and out of the space.

The modular room is one part of this collaboration among Fralin Biomedical Research Institute at Virginia Tech Carilion, Verge, Virginia Tech, Montgomery County and Roanoke. The partners will work toward surveying regional and statewide cleanroom needs in life science and biotechnology industries, according to the news release.

Spencer Marsh, Tiny Cargo’s chief scientific officer, credited Fralin Biomedical with identifying the need. In the news release, he said that cleanrooms will help GO Virginia’s Region 2 retain startups and foster growth. The Region 2 companies that require them don’t have access here, he said. Marsh’s company and the others will use the modular room to create sterile products for clinical trials.

“Modular cleanroom spaces may be able to fill this need and can be installed within existing facilities at a much lower cost than full-scale new construction,” Marsh said.

Tiny Cargo works to corral milk exosomes to transport therapeutics to humans dealing with radiation treatment for cancer. The exosomes, cells’ cargo-delivery system, might also treat other diseases.

Qentoros makes Bio-Ply, which its website says is proven to promote healing and reduce inflammation in horses with musculoskeletal injuries.

Acomhal Research is developing drugs to treat primary cancer tumors in hopes of lowering recurrences and metastasis, according to its website.

The three companies were selected last year to be the first cohort for the Johnson & Johnson Innovation JLabs virtual residency, in a Johnson & Johnson and Virginia Tech Corporate Research Center collaboration.

Recent News

02/11/2025

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions,  announced a strategic partnership with BRAINBox Solutions, a leader in multi-modality diagnostics for traumatic brain injury (TBI). This collaboration seeks to develop the first intranasal therapy for mild traumatic brain injury (mTBI) aka concussion, creating a comprehensive trigger-to-treat

02/10/2025

AIN Ventures and VIPC Invest in Cerbrec to Accelerate AI Innovation

Cerbrec, a leading Virginia-based AI platform provider, announced that AIN Ventures has invested in its seed funding round. This investment will enable Cerbrec to accelerate its mission of equipping biotech and pharmaceutical companies, along with those in other industries, with cutting-edge tools for creating tailored AI solutions. Cerbrec’s flagship product, Graphbook, is an innovative drag-and-drop

02/05/2025

Project Vital bringing millions in funding to Roanoke-Blacksburg’s life sciences

The Roanoke-Blacksburg region is establishing itself as a biomedical research hub and medical device innovation center. About $5 million from the state could help move that work from labs to markets. Those millions will fund Project Vital: Virginia Innovations and Technology Advancements in Life Sciences. It’s a collaboration among the Roanoke-Blacksburg Innovation Alliance (formerly Verge),